Drug intelligence / Profile preview

rhus coriaria

Development stage: Preclinical
Administration: Oral

Overview

Rhus coriaria, commonly known as sumac, is a flowering shrub belonging to the Anacardiaceae family. It produces clusters of bright red, pea-sized fruits that are typically dried and ground into powder for use as a culinary spice and in herbal medicine. The plant contains numerous bioactive compounds with therapeutic properties, including antioxidant, antimicrobial, anti-inflammatory, antidiabetic, anticancer, and antidepressant effects. It has been traditionally used in Mediterranean and Middle Eastern cuisines and in homeopathic therapy for various health conditions.

Brand names: Sumac
Other names: Syrian sumac

Targets

CA1 (Carbonic anhydrase 1)CA2 (Carbonic Anhydrase 2)ButyrylcholinesteraseAcetylcholinesteraseCA12 (Carbonic anhydrase XII)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on rhus coriaria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on rhus coriaria.

Explore the full profile